Stay Alert for Patients Stopping Dopamine Agonists

Health Canada is warning about the risk of withdrawal symptoms when stopping dopamine agonists (pramipexole, ropinirole, etc).

These meds are often used for Parkinson's disease, restless legs syndrome, or other conditions.

But some patients who stop or reduce the dose of these meds experience "dopamine agonist withdrawal syndrome" (DAWS).

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote